retatrutide mechanism triple agonist glp-1 gip glucagon Schematic illustration of monoagonists, dual agonists and Retatrutide vs Semaglutide: Triple vs
Description
After a 20-week titration phase, the participants were followed for another 52 weeks
Statement on a nonproprietary name adopted by the USAN Council: Eloralintide
Archives Internationales de Physiologie
Once stable, monitoring every three to six months is appropriate, reducing to six-monthly when control is well established
The cagrilintide side effect profile adds some considerations beyond standard GLP-1 effects
Currently, nearly 100 million people globally are affected by DR, and as the prevalence of diabetes continues to rise, this number is expected to grow, posing a significant burden on public health (82)
